Results 171 to 180 of about 2,412,470 (291)

A sustainable business ecosystem: a case study demonstrating biochar's potential

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract The need for renewable, climate‐friendly resources has become urgent as legislators worldwide have sought to find ways to cut emissions while ensuring resource security for consumers. The use of biochar could help to achieve these goals. This study examines the current state of commercial biochar production and the maturity of the related ...
Kivijakola Juuso, Erkheikki Eemeli, Lukka Viljo, Tervonen Pekka, Harri Haapasalo   +4 more
wiley   +1 more source

Striking a Balance With Business and Engineering Content in Biomedical Engineering Capstone Design. [PDF]

J Biomech Eng
Eberhardt AW.
europepmc   +1 more source

Socioenvironmental implications of Jatropha curcas cultivation for biodiesel supply in postmining communities

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract The long‐term viability of Jatropha curcas as a biodiesel feedstock has been widely debated. Many early initiatives failed to deliver consistent economic returns despite promising environmental attributes. This study re‐evaluated J. curcas‐based systems within an integrated environmental–economic framework, focusing on their potential role in ...
Eduardo Sansão Sozinho Maurício, Ronaldo Carrion, Célio Bermann, Nildeir Silva   +3 more
wiley   +1 more source

A framework for implementing high-quality dementia care navigation: recommendations from the Alzheimer's Association Dementia Care Navigation Roundtable. [PDF]

Alzheimers Dement
Daven M, Bass DM, Deaner N, Sawyer RJ, Evertson L, Reuben DB, Alzheimer's Association Dementia Care Navigation Roundtable.   +6 more
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Building an intelligent brain platform for small and medium-sized enterprises using ChatGLM and Multi-Agent Systems. [PDF]

PLoS One
Yuan D.
europepmc   +1 more source

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

British Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

Empirically assessing corporate adaptation and resilience disclosure using AI. [PDF]

NPJ Clim Action
Spacey Martín R, Ranger N, Schimanski T, Leippold M.   +3 more
europepmc   +1 more source

Evaluating TOD performance through node-place model: evidence from bus stop areas in Windhoek, Namibia. [PDF]

Front Public Health
Cui N, Yang H, Mwetuhafifa NM.
europepmc   +1 more source

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden, Miriam G. Mooij, Matthijs de Hoog, Saskia N. de Wildt   +3 more
wiley   +1 more source